Dec 13, 20216 minANNOUNCEMENTSMEDSIR’s On Site Experience from SABCS 2021: Update on our 5 studies presented
Nov 29, 20213 minCANCER RESEARCHCancer Vaccine could be key to modulating tumor microenvironment for metastatic pancreatic cancer
Nov 9, 20213 minANNOUNCEMENTSResults from AZENT Trial have been just published on European Journal of Cancer
Oct 22, 20213 minANNOUNCEMENTSMEDSIR at SEOM 2021: Update on the Recruitment Status of the DEBBRAH Study
Oct 21, 20213 minCANCER RESEARCHToripalimab joins the list of ICIs that improve efficacy when added to chemotherapy in 1L NSCLC
Oct 18, 20218 minCANCER RESEARCHDr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer
Oct 12, 20213 minCANCER RESEARCHDESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer
Oct 7, 20212 minANNOUNCEMENTSPARSIFAL: Identifying an endocrine agent for palbociclib in endocrine sensitive ABC
Sep 30, 20214 minCANCER RESEARCHPembrolizumab may be the new standard of care for RCC with intermediate to high risk of recurrence
Sep 16, 20214 minANNOUNCEMENTSMEDSIR at ESMO 2021: Presentation of DEBBRAH and PATHFINDER study design
Sep 10, 20213 minCANCER RESEARCHIpilimumab-nivolumab combo as 2L does not improve survival for immunotherapy naive NSCLC
Sep 2, 20213 minANNOUNCEMENTSCOPERNICO Results at ERS: immunotherapy combo reduces hospitalization for COVID-19 pneumonia
Aug 27, 20211 minINTERVIEWSEl Global Interview: in a post-pandemic world, clinical research needs to be made even more flexible
Aug 23, 20212 minCANCER RESEARCHCOVID-19 Pandemic created a cancer screening deficit in the United States
Aug 23, 20212 minCANCER RESEARCHApalutamide plus ADT improves overall survival in metastatic castration-sensitive prostate cancer
Aug 19, 20216 minINTERVIEWSORPHEUS: A study of the efficacy of immunotherapy for advanced cases of penile cancer
Aug 10, 20213 minANNOUNCEMENTSNew trial to evaluate abemaciclib and endocrine therapy vs. chemotherapy in advanced breast cancer
Jul 16, 20213 minCANCER RESEARCHUp to 30% of patients with metastatic breast cancer develop brain disease
